Yu‐Long Lan

1.4k total citations
48 papers, 1.1k citations indexed

About

Yu‐Long Lan is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yu‐Long Lan has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yu‐Long Lan's work include Ion Transport and Channel Regulation (11 papers), Glioma Diagnosis and Treatment (6 papers) and Estrogen and related hormone effects (6 papers). Yu‐Long Lan is often cited by papers focused on Ion Transport and Channel Regulation (11 papers), Glioma Diagnosis and Treatment (6 papers) and Estrogen and related hormone effects (6 papers). Yu‐Long Lan collaborates with scholars based in China, United States and United Kingdom. Yu‐Long Lan's co-authors include Jiacheng Lou, Shao Li, Jie Zhao, Xiaochi Ma, Jinshan Xing, Bo Zhang, Shuang Zou, Bo Zhang, Xun Wang and Zhenlong Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Oncotarget.

In The Last Decade

Yu‐Long Lan

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Long Lan China 23 518 182 131 117 112 48 1.1k
Rikang Wang China 20 512 1.0× 122 0.7× 117 0.9× 108 0.9× 121 1.1× 44 1.0k
Adel Rezaei Moghadam Iran 12 660 1.3× 230 1.3× 144 1.1× 100 0.9× 250 2.2× 17 1.6k
Weijiang Zhao China 21 665 1.3× 339 1.9× 149 1.1× 181 1.5× 141 1.3× 86 1.4k
Xiaojie Zhang China 21 367 0.7× 101 0.6× 85 0.6× 97 0.8× 143 1.3× 61 1.0k
Haiying Ma China 21 585 1.1× 76 0.4× 135 1.0× 80 0.7× 125 1.1× 45 1.0k
Tiandong Leng United States 22 662 1.3× 188 1.0× 183 1.4× 63 0.5× 94 0.8× 47 1.2k
Honghai Wu China 22 700 1.4× 192 1.1× 117 0.9× 301 2.6× 105 0.9× 64 1.6k
Y Liu China 21 497 1.0× 190 1.0× 152 1.2× 135 1.2× 159 1.4× 75 1.3k

Countries citing papers authored by Yu‐Long Lan

Since Specialization
Citations

This map shows the geographic impact of Yu‐Long Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Long Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Long Lan more than expected).

Fields of papers citing papers by Yu‐Long Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Long Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Long Lan. The network helps show where Yu‐Long Lan may publish in the future.

Co-authorship network of co-authors of Yu‐Long Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Long Lan. A scholar is included among the top collaborators of Yu‐Long Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Long Lan. Yu‐Long Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Qi, et al.. (2024). Update on the roles of regular daily rhythms in combating brain tumors. European Journal of Pharmacology. 986. 177144–177144. 1 indexed citations
3.
Lan, Yu‐Long, et al.. (2024). Analysis of the sodium pump subunit ATP1A3 in glioma patients: Potential value in prognostic prediction and immunotherapy. International Immunopharmacology. 133. 112045–112045. 3 indexed citations
4.
Lan, Yu‐Long, et al.. (2023). Potential roles of transformers in brain tumor diagnosis and treatment. SHILAP Revista de lepidopterología. 1(2). 11 indexed citations
5.
Lan, Yu‐Long, et al.. (2023). Shed a New Light on Spinal Cord Injury-induced Permanent Paralysis with the Brain-spine Interface. Neuroscience Bulletin. 39(12). 1898–1900. 2 indexed citations
6.
Lan, Yu‐Long, et al.. (2022). Identification of the prognostic and immunological roles of aquaporin 4: A potential target for survival and immunotherapy in glioma patients. Frontiers in Cellular Neuroscience. 16. 1061428–1061428. 8 indexed citations
7.
Lan, Yu‐Long & Jianmin Zhang. (2021). Modulation of untranslated region alternative polyadenylation in glioma tumorigenesis. Biomedicine & Pharmacotherapy. 137. 111416–111416. 4 indexed citations
8.
Zou, Shuang, Yu‐Long Lan, Xiangyü Li, et al.. (2021). A Bioinformatics Analysis of the Potential Roles of Aquaporin 4 in Human Brain Tumors: An Immune-Related Process. Frontiers in Pharmacology. 12. 692175–692175. 7 indexed citations
10.
Lan, Yu‐Long, et al.. (2019). Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders. Therapeutic Advances in Endocrinology and Metabolism. 10. 2388797876–2388797876. 28 indexed citations
11.
Peng, Yulin, Yan Wang, Ning Tang, et al.. (2018). Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway. Journal of Experimental & Clinical Cancer Research. 37(1). 248–248. 134 indexed citations
12.
Lan, Yu‐Long, et al.. (2018). Update on the clinical application of deep brain stimulation in sleep dysfunction of Parkinson’s disease. Acta Neurologica Belgica. 118(3). 351–359. 3 indexed citations
13.
Lan, Yu‐Long, Xun Wang, Jiacheng Lou, et al.. (2018). Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na+/K+-ATPase α1 subunit. Biomedicine & Pharmacotherapy. 103. 204–215. 29 indexed citations
14.
Lan, Yu‐Long, Junjun Zhou, Jing Liu, et al.. (2018). Uncaria rhynchophylla Ameliorates Parkinson’s Disease by Inhibiting HSP90 Expression: Insights from Quantitative Proteomics. Cellular Physiology and Biochemistry. 47(4). 1453–1464. 44 indexed citations
15.
Lan, Yu‐Long, Xun Wang, Jiacheng Lou, et al.. (2017). Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies. Journal of Neuro-Oncology. 137(2). 357–365. 17 indexed citations
16.
Lou, Jiacheng, Yu‐Long Lan, Jinxia Gao, et al.. (2017). Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway. Frontiers in Molecular Neuroscience. 10. 420–420. 22 indexed citations
17.
Lan, Yu‐Long, Shuang Zou, Changfu Zhang, et al.. (2016). Update on the effect of estradiol in postmenopause women with Alzheimer’s disease: a systematic review. Acta Neurologica Belgica. 116(3). 249–257. 6 indexed citations
18.
Lan, Yu‐Long, Xun Wang, Jinshan Xing, et al.. (2016). The potential roles of dopamine in malignant glioma. Acta Neurologica Belgica. 117(3). 613–621. 22 indexed citations
19.
Lan, Yu‐Long, Jie Zhao, Tonghui Ma, & Shao Li. (2015). The Potential Roles of Aquaporin 4 in Alzheimer’s Disease. Molecular Neurobiology. 53(8). 5300–5309. 45 indexed citations
20.
Lan, Yu‐Long, Jie Zhao, & Shao Li. (2014). Estrogen receptors’ neuroprotective effect against glutamate-induced neurotoxicity. Neurological Sciences. 35(11). 1657–1662. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026